ニュース

Nov 16 (Reuters) - Eliquis, a promising blood clot preventer from Bristol-Myers Squibb and Pfizer, has a decent chance at getting an accelerated review by U.S. health regulators in coming months ...
Nov 16 (Reuters) - Eliquis, a promising blood clot preventer from Bristol-Myers Squibb and Pfizer, has a decent chance at getting an accelerated review by U.S. health regulators in coming months ...